Cannabinoid receptor 1 and 2 (CB1 and CB2) are G-protein-coupled receptors involved in neurogenic and inflammatory pain and itch, and their agonism showed antipruritic effects at both the central and peripheral levels, in systemic and dermatologic diseases, as well as AD and ACD. This evidence concerns the gene CNR1 and Alzheimer disease.